Akt3 overexpression in the heart results in progression from adaptive to maladaptive hypertrophy
- PMID: 15698844
- DOI: 10.1016/j.yjmcc.2004.12.002
Akt3 overexpression in the heart results in progression from adaptive to maladaptive hypertrophy
Abstract
Akt is a serine/threonine kinase that mediates a variety of cellular responses to external stimuli. Among the three members of mammalian Akt (Akt1, Akt2 and Akt3), Akt3 is unique in that it has an alternatively spliced variant that lacks the carboxy-terminal regulatory phosphorylation site. However, little is known regarding in vivo functions of Akt3 and its spliced variant. In this study we investigated the potential functions of the Akt3 spliced variant by overexpressing its activated form in the heart. Cardiac-specific Akt3 transgenic (TG) mice exhibited marked cardiac hypertrophy. Contractile function of TG hearts was preserved at 4 and 12 weeks, but was impaired at 20 weeks of age. When treated with cardiotoxic drug doxorubicin (Dox), TG mice at 4 weeks of age exhibited improved survival and preserved contractile function. However, these cardioprotective effects were not evident when Dox was injected at 12 weeks of age, and TG mice exhibited even higher mortality rate than wild-type animals when Dox was injected at 20 weeks of age. Endogenous Akt1 and Akt2 protein and phosphorylation levels were downregulated in Akt3 TG hearts, suggesting the existence of negative feedback regulation of Akt signaling at the level of Akt protein amount. Taken together, the Akt3 spliced variant is functional in vivo, promotes cardiac growth and mediates cardioprotective effects. However, continuous overexpression of Akt3 results in contractile dysfunction and increased susceptibility to cardiac injury. Thus, sustained activation of Akt signaling results in progression from adaptive to maladaptive hypertrophy.
Similar articles
-
AKT involvement in cisplatin chemoresistance of human uterine cancer cells.Gynecol Oncol. 2004 Sep;94(3):785-95. doi: 10.1016/j.ygyno.2004.06.023. Gynecol Oncol. 2004. PMID: 15350374
-
Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways.J Mol Cell Cardiol. 2012 Feb;52(2):493-501. doi: 10.1016/j.yjmcc.2011.10.015. Epub 2011 Oct 26. J Mol Cell Cardiol. 2012. PMID: 22056317
-
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.Nat Med. 2005 Feb;11(2):214-22. doi: 10.1038/nm1175. Epub 2005 Jan 23. Nat Med. 2005. PMID: 15665834
-
Functional and therapeutic significance of Akt deregulation in malignant melanoma.Cancer Metastasis Rev. 2005 Jun;24(2):273-85. doi: 10.1007/s10555-005-1577-9. Cancer Metastasis Rev. 2005. PMID: 15986137 Review.
-
Regulation of cell size and contractile function by AKT in cardiomyocytes.Ann N Y Acad Sci. 2004 May;1015:250-60. doi: 10.1196/annals.1302.021. Ann N Y Acad Sci. 2004. PMID: 15201165 Review.
Cited by
-
PI3K Phosphorylation Is Linked to Improved Electrical Excitability in an In Vitro Engineered Heart Tissue Disease Model System.Tissue Eng Part A. 2015 Sep;21(17-18):2379-89. doi: 10.1089/ten.TEA.2014.0412. Epub 2015 Aug 7. Tissue Eng Part A. 2015. PMID: 26120935 Free PMC article.
-
Molecular and structural transition mechanisms in long-term volume overload.Eur J Heart Fail. 2016 Apr;18(4):362-71. doi: 10.1002/ejhf.465. Epub 2015 Dec 23. Eur J Heart Fail. 2016. PMID: 26694078 Free PMC article.
-
Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.J Clin Invest. 2007 Nov;117(11):3211-23. doi: 10.1172/JCI31757. J Clin Invest. 2007. PMID: 17965779 Free PMC article.
-
Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase.J Biol Chem. 2008 Oct 31;283(44):29730-9. doi: 10.1074/jbc.M805514200. Epub 2008 Sep 4. J Biol Chem. 2008. PMID: 18772130 Free PMC article.
-
Gene expression and genetic variation in human atria.Heart Rhythm. 2014 Feb;11(2):266-71. doi: 10.1016/j.hrthm.2013.10.051. Epub 2013 Oct 28. Heart Rhythm. 2014. PMID: 24177373 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous